Literature DB >> 12722119

Cervicovaginal (Papanicolaou) smear findings in patients with malignant mixed Müllerian tumors.

Mary B Casey1, Jill L Caudill, Diva R Salomão.   

Abstract

Malignant mixed Müllerian tumor is a rare neoplasm that occurs most frequently in elderly patients. It is characterized by a mixture of malignant epithelial and sarcomatous components. Little has been published about Papanicolaou smear findings pertaining to malignant mixed Müllerian tumors. We present our experience, with an emphasis on cytologic detail. Nine patients (median age, 65 yr) met our study criteria. All available smears and surgical specimens were reviewed. Four smears were positive for malignancy, with a sensitivity of 44% (3 adenocarcinoma, and 1 squamous-cell carcinoma, small-cell type). The results of our study showed that Papanicolaou smear findings pertaining to malignant mixed Müllerian tumors are seen in patients with advanced-stage disease with involvement of the lower uterine segment or cervix. The usual finding is large numbers of high-grade epithelial malignant cells in a necrotic background. The mesenchymal component rarely sheds cells visible on Papanicolaou smear. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12722119     DOI: 10.1002/dc.10276

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  USG Guided Fine Needle Aspiration Cytology along with Immunocytochemistry to Diagnose Primary Malignant Mixed Mullerian Tumors: A Three-Year Study from a Tertiary Care Center.

Authors:  Radhika Agarwal; Meeta Singh; Sneha Goswami; Shramana Mandal; Devender Verma; Nita Khurana; Shyama Jain; Nidhi Verma
Journal:  J Cytol       Date:  2022-01-21       Impact factor: 1.000

Review 2.  Cytomorphology of unusual primary tumors in the Pap test.

Authors:  Walid E Khalbuss; Liron Pantanowitz; Sara E Monaco
Journal:  Cytojournal       Date:  2013-08-30       Impact factor: 2.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.